Baltimore, MD, United States of America

Scheberazade Sadegh-Nasseri


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scheberazade Sadegh-Nasseri: Innovator in Immunogenicity Testing

Introduction

Scheberazade Sadegh-Nasseri is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of immunology through his innovative work on peptide immunogenicity. His research focuses on developing methods that enhance our understanding of immune responses, which are crucial for vaccine development.

Latest Patents

Sadegh-Nasseri holds 1 patent for his invention titled "Model for testing immunogenicity of peptides." This patent describes assay methods that determine whether a peptide is likely to be immunogenic. The methods are based on computer modeling of binding to a Class II MHC DR1 receptor, which is confirmed by competitive inhibition binding assays. The peptides developed through this research are useful for eliciting immune responses for vaccination or the production of antibodies or T-cells.

Career Highlights

Sadegh-Nasseri is currently employed by the US Government as represented by the Secretary of the Army. His work in this capacity allows him to contribute to important research that has implications for national defense and public health.

Collaborations

Throughout his career, Sadegh-Nasseri has collaborated with esteemed colleagues, including Jeffrey Nauss and Robert H Reid. These collaborations have furthered his research and expanded the impact of his work in the field of immunology.

Conclusion

Scheberazade Sadegh-Nasseri is a pioneering inventor whose work on immunogenicity testing is paving the way for advancements in vaccine development and immune response research. His contributions are vital to the ongoing efforts in immunology and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…